HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jérôme Honnorat Selected Research

anti-NMDA receptor autoantibody

1/2018Molecular Pathogenicity of Anti-NMDA Receptor Autoantibody From Patients With First-Episode Psychosis.
1/2017Clinical and autoimmune features of a patient with autism spectrum disorder seropositive for anti-NMDA-receptor autoantibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jérôme Honnorat Research Topics

Disease

44Neoplasms (Cancer)
08/2022 - 11/2004
22Encephalitis (Encephalitis, Rasmussen)
01/2022 - 11/2010
17Glioblastoma (Glioblastoma Multiforme)
05/2022 - 04/2007
16Glioma (Gliomas)
01/2022 - 09/2007
15Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
03/2022 - 11/2009
13Autoimmune Diseases of the Nervous System
01/2022 - 05/2012
8Cerebellar Ataxia (Dysmetria)
08/2022 - 05/2010
8Autoimmune Diseases (Autoimmune Disease)
01/2022 - 11/2008
7Paraneoplastic Cerebellar Degeneration
01/2022 - 03/2010
6Seizures (Absence Seizure)
01/2022 - 07/2011
6Nervous System Diseases (Neurological Disorders)
07/2021 - 05/2007
6Ataxia (Dyssynergia)
01/2021 - 05/2010
5Anti-N-Methyl-D-Aspartate Receptor Encephalitis
12/2021 - 11/2010
5Brain Neoplasms (Brain Tumor)
11/2021 - 07/2006
5Thymoma (Thymic Carcinoma)
10/2020 - 05/2006
5Stroke (Strokes)
01/2013 - 11/2003
4Disease Progression
01/2022 - 08/2011
4Neuromyelitis Optica (Devic's Disease)
09/2010 - 03/2007
4Ischemic Stroke
01/2005 - 01/2002
3Myasthenia Gravis
03/2022 - 03/2017
3Alzheimer Disease (Alzheimer's Disease)
01/2022 - 03/2009
3Inflammation (Inflammations)
12/2021 - 05/2010
3Genetic Predisposition to Disease (Genetic Predisposition)
12/2021 - 07/2020
3Epilepsy (Aura)
08/2021 - 06/2013
3Stiff-Person Syndrome (Stiff Man Syndrome)
07/2021 - 06/2013
3Isaacs Syndrome (Neuromyotonia)
10/2020 - 01/2016
3Nervous System Paraneoplastic Syndromes
01/2020 - 09/2015
3Schizophrenia (Dementia Praecox)
01/2019 - 01/2015
3Mental Disorders (Mental Disorder)
05/2018 - 05/2012
3Psychotic Disorders (Schizoaffective Disorder)
01/2018 - 12/2013
3Brain Diseases (Brain Disorder)
01/2018 - 05/2012
2Meningitis
03/2022 - 01/2021
2Lung Neoplasms (Lung Cancer)
03/2022 - 07/2006
2Central Nervous System Diseases (CNS Diseases)
03/2022 - 01/2016
2Leukocytosis (Pleocytosis)
10/2021 - 01/2014
2Temporal Lobe Epilepsy
07/2021 - 07/2020
2Hypoxia (Hypoxemia)
01/2021 - 09/2010
2Necrosis
01/2021 - 02/2011
2Teratoma (Teratoid Tumor)
01/2021 - 11/2019
2Demyelinating Diseases (Demyelinating Disease)
01/2021 - 09/2010
2Cranial Nerve Diseases (Cranial Nerve Disorders)
01/2021 - 01/2021
2Cerebellar Diseases (Cerebellar Syndrome)
12/2020 - 06/2013
2Colorectal Neoplasms (Colorectal Cancer)
10/2020 - 03/2017
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2020 - 01/2015
2Tertiary Lymphoid Structures
11/2019 - 01/2018
2Immune System Diseases (Immune Disorders)
01/2019 - 01/2018
2Myelitis
03/2017 - 12/2013
2Hashimoto's encephalitis
04/2016 - 01/2015
2Pituitary Neoplasms (Pituitary Adenoma)
01/2016 - 03/2012
2Neuroendocrine Carcinoma
09/2015 - 11/2008
2Neurodegenerative Diseases (Neurodegenerative Disease)
09/2015 - 08/2003

Drug/Important Bio-Agent (IBA)

44AntibodiesIBA
03/2022 - 01/2002
20AutoantibodiesIBA
01/2022 - 05/2008
19Proteins (Proteins, Gene)FDA Link
12/2021 - 08/2003
17N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2021 - 11/2010
10Temozolomide (Temodar)FDA LinkGeneric
05/2018 - 09/2007
8AntigensIBA
08/2022 - 11/2004
7Biomarkers (Surrogate Marker)IBA
05/2022 - 05/2008
7Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
07/2021 - 01/2015
6Leucine (L-Leucine)FDA Link
01/2022 - 10/2020
6N-Methylaspartate (NMDA)IBA
05/2018 - 09/2010
5Immune Checkpoint InhibitorsIBA
08/2022 - 11/2019
4Surface Antigens (Surface Antigen)IBA
08/2022 - 01/2016
4LigandsIBA
03/2022 - 04/2017
4Biological ProductsIBA
01/2022 - 05/2010
4Immunoglobulin G (IgG)IBA
12/2020 - 05/2008
4Bevacizumab (Avastin)FDA Link
05/2018 - 02/2011
4Semaphorin-3AIBA
04/2012 - 08/2003
4Tissue Plasminogen Activator (Alteplase)FDA Link
10/2004 - 01/2002
3anti-Yo autoantibodiesIBA
01/2022 - 01/2018
3EpitopesIBA
01/2019 - 06/2013
3anti-CASPR2 autoantibodyIBA
01/2019 - 01/2015
3Lomustine (CCNU)FDA Link
05/2018 - 01/2015
3Glutens (Glutelin)IBA
01/2018 - 01/2015
3Vincristine (Oncovin)FDA LinkGeneric
06/2017 - 09/2012
3Procarbazine (Matulane)FDA Link
06/2017 - 09/2012
3Protein Isoforms (Isoforms)IBA
01/2015 - 03/2013
2Programmed Cell Death 1 ReceptorIBA
03/2022 - 01/2021
2Glial Fibrillary Acidic ProteinIBA
01/2022 - 05/2020
2Amyloid beta-PeptidesIBA
01/2022 - 11/2021
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2022 - 01/2020
2CytokinesIBA
12/2021 - 01/2021
2EverolimusFDA Link
11/2021 - 03/2012
2Peptides (Polypeptides)IBA
01/2021 - 05/2006
2metabotropic glutamate receptor type 1IBA
12/2020 - 05/2010
2Netrin-1IBA
10/2020 - 03/2017
2NivolumabIBA
11/2019 - 01/2018
2Irinotecan (Camptosar)FDA LinkGeneric
05/2018 - 01/2014
2anti-NMDA receptor autoantibodyIBA
01/2018 - 01/2017
2Glutamic Acid (Glutamate)FDA Link
11/2017 - 09/2010
2Histones (Histone)IBA
08/2017 - 03/2016
2Immunosuppressive Agents (Immunosuppressants)IBA
10/2016 - 01/2015
2AcidsIBA
10/2015 - 09/2010
2Telomerase (Telomerase Reverse Transcriptase)IBA
07/2015 - 02/2013

Therapy/Procedure

12Drug Therapy (Chemotherapy)
05/2018 - 07/2006
11Therapeutics
03/2022 - 11/2003
11Radiotherapy
07/2015 - 07/2006
8Immunotherapy
08/2022 - 06/2013
2Precision Medicine
11/2021 - 02/2013
2Aftercare (After-Treatment)
11/2019 - 01/2015